a large number of syntheses (enantioselective synthesis and
enzymatic resolution) have been developed for enantiopure
alicyclic â-amino acid13 and â-lactam14-16 derivatives. One
good possibility for the preparation of enantiopure â-lactams
is an enantioselective enzyme-catalyzed hydrolysis of acti-
vated â-lactams.14 As an example, Adam et al. described the
simultaneous preparation of enantiopure amino acids and
â-lactams from R-methylene â-lactams by lipase-catalyzed
kinetic resolution through hydrolysis.14a Achilles et al.
described the enzyme-catalyzed hydrolysis of ethyl (()-2-
(2-oxo-4-phenylazetidin-1-yl)acetate with R-chymotrypsin.14b
However, these ring-opening methods have been limited to
activated â-lactams (activated with N-acyl-protecting groups
such as tert-butoxycarbonyl or acetyl). Evans et al. inves-
tigated the enzymatic ring-opening reactions of unactivated
(()-6-azabicyclo[3.2.0]-hept-3-en-7-one, and found that lac-
tamases in a special whole-cell preparation, ENZA-1 (Rhodo-
coccus equi NCIMB 40213), catalyzed the enantioselective
ring opening of this compound in water.15 Interestingly, the
saturated â-lactam remains intact under the same conditions.
An important indirect enzymatic route for enantiopure
alicyclic â-amino acid derivatives and â-lactams is through
lipase-catalyzed asymmetric acylation of the N-hydroxy-
methylated â-lactams or lipase-catalyzed hydrolysis of the
corresponding ester derivatives in an organic solvent.16,17
In this paper, we report a new direct method for the
enantioselective ring opening of unactivated cyclic â-lactams
(()-1-(()-4, yielding the ring-opened â-amino acids 1a-
4a and unreacted â-lactam enantiomers 1b-4b, which could
be easily separated (Scheme 1).
70 °C.14a Since they mentioned that the enzyme rapidly lost
activity at higher temperatures, we started our experiments
with Chirazyme L-2 (a carrier-fixed lipase B from Candida
antarctica) at 60 °C, but instead of water the ring-opening
reactions of (()-1-(()-4 were performed in diisopropyl
ether, using water (1 equiv) as nucleophile (Table 1, entries
Table 1. Conversion and Enantioselectivity of Ring Opening
of (()-1-(()-4
b
c
enzyme
H2O
conv ees eep
entry compda
(50 mg mL-1
)
(equiv) (%) (%) (%)
E
1d
2d
3d
4d
5d
6e
7e
8d
9e
10e
11e
12e
13e
14d
15d
16d
17d
(()-1
(()-1
(()-2
(()-2
(()-3
(()-3
(()-3
(()-3
(()-3
(()-3
(()-3
(()-3
(()-3
(()-3
(()-3
(()-4
(()-4
Chirazyme L-2
Lipolase
1
1
14
19
25
29
41
32
30
48
49
46
43
30
13
40
18
19
20
16 >95 >45
22 >95 >48
31 >95 >52
39 >95 >57
67 >95 >78
45 >95 >60
40 >95 >57
89 >95 >117
90 >95 >120
82 >95 >99
73 >95 >85
40 >95 >57
14 >95 >44
63 >95 >74
21 >95 >47
22 >95 >48
24 >95 >49
Chirazyme L-2
Lipolase
1
1
Chirazyme L-2
Chirazyme L-2
Chirazyme L-2
Lipolase
1
2
3
1
Lipolase
-
Lipolase
2
Lipolase
3
Lipolase
4
Lipolase
10
1
Novozyme 435
CAL-A
1
Chirazyme L-2
Lipolase
1
1
a 0.05 M substrate in diisopropyl ether, 60 °C. b According to GC.
c Calculated by using an internal standard (hexadecane). d After 20 h. e After
23 h.
1, 3, 5, and 16). High enantioselectivities but rather long
reaction times were observed. An additional enzyme screen-
ing including lipase PS (Pseudomonas cepacia), lipase AK
(Pseudomonas fluorescens), lipase AY (Candida rugosa),
Scheme 1. Enantioselective Ring Opening of Unactivated
Cyclic â-Lactams (()-1-(()-4
(13) (a) Faulconbridge, S. J.; Holt, K. E.; Sevillano, L. G.; Lock, C. J.;
Tiffin, P. D.; Tremayne, N.; Winter, S. Tetrahedron Lett. 2000, 41, 2679-
2681. (b) Bolm, C.; Dinter, C. L.; Sciffers, I.; Defre`re, L. Synlett 2001, 12,
1875-1877. (c) Yokota, Y.; Cortez, G. S.; Romo, D. Tetrahedron 2002,
58, 7075-7080. (d) Liu, M.; Sibi, M. P. Tetrahedron 2002, 58, 7991-
8035. (e) Aggarwal, V. K.; Roseblade, S. J.; Barrell, J. K.; Alexander, R.
Org. Lett. 2002, 4, 1227-1229. (f) Woll, M. G.; Fisk, J. D.; LePlae, P. R.;
Gellman, S. H. J. Am. Chem. Soc. 2002, 124, 12447-12452. (g) Porter, E.
A.; Wang, X. F.; Schmitt, M. A.; Gellman, S. H. Org. Lett. 2002, 4, 3317-
3319.
(14) (a) Adam, W.; Groer, P.; Humpf, H.-U.; Saha-Mo¨ller, C. R. J. Org.
Chem. 2000, 65, 4919-4922. (b) Achilles, K.; Schirmeister, T.; Otto, H.-
H. Arch. Pharm. Pharm. Med. Chem. 2000, 333, 243-253.
(15) Evans, C.; McCague, R.; Roberts, S. M.; Sutherland, A. G.; Wisdom,
R. J. Chem. Soc., Perkin Trans. 1 1991, 2276-2277.
The alicyclic â-lactams (()-1-(()-3 were prepared by
1,2-dipolar cycloaddition of chlorosulfonyl isocyanate (CSI)
to the corresponding cycloalkene,18 while (()-4 was obtained
by means of CSI cycloaddition to cyclooctadiene19 and
subsequent catalytic reduction in the presence of cyclohexene
as a hydrogen donor.17d
Adam et al. reported on the highly enantioselective
hydrolysis of the N-substituted â-lactam derivatives (E
usually >200) with the lipase Chirazyme L-2, in water at
(16) Nagai, H.; Shiozawa, T.; Achiwa, K.; Terao, Y. Chem. Pharm. Bull.
1993, 41, 1933-1938.
(17) (a) Csomo´s, P.; Kanerva, L. T.; Berna´th, G.; Fu¨lo¨p, F. Tetrahedron:
Asymmetry 1996, 7, 1789-1796. (b) Ka´ma´n, J.; Forro´, E.; Fu¨lo¨p, F.
Tetrahedron: Asymmetry 2000, 11, 1593-1600. (c) Fu¨lo¨p, F.; Palko´, M.;
Ka´ma´n, J.; La´za´r, L.; Sillanpa¨a¨, R. Tetrahedron: Asymmetry 2000, 11,
4179-4187. (d) Forro´, E.; AÄ rva, J.; Fu¨lo¨p, F. Tetrahedron: Asymmetry 2001,
12, 643-649.
(18) (a) Nativ, E.; Rona, P. Isr. J. Chem. 1972, 10, 55-58. (b) Singh,
R.; Cooper, R. D. G. Tetrahedron 1994, 50, 12049-12064. (c) Furet, P.;
Garcia-Echeverria, C.; Gay, B.; Scoepfer, J.; Zeller, M.; Rahuel, J. J. Med.
Chem. 1999, 42, 2358-2363.
(19) (a) Parsons, P. J.; Camp, N. P.; Underwood, J. M.; Harvey, D. M.
Tetrahedron 1996, 52, 11637-11642. (b) Parsons, P. J.; Camp, N. P.;
Edwards, N.; Sumoreeah, L. R. Tetrahedron 2000, 56, 309-315.
(12) (a) Cabell, L. A.; McMurray, J. S. Tetrahedron Lett. 2002, 43,
2491-2493. (b) Alcaide, B.; Almendros, P.; Alonso, J. M.; Aly, M. F.;
Pardo, C.; Saez, E.; Torres, M. R. J. Org. Chem. 2002, 67, 7004-7013.
1210
Org. Lett., Vol. 5, No. 8, 2003